209 related articles for article (PubMed ID: 10835711)
1. [Present and future of oral anticoagulants].
Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
[TBL] [Abstract][Full Text] [Related]
2. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
Scardi S; Giansante C
Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
[TBL] [Abstract][Full Text] [Related]
3. Orally active direct thrombin inhibitors.
Weitz J
Semin Vasc Med; 2003 May; 3(2):131-8. PubMed ID: 15199476
[TBL] [Abstract][Full Text] [Related]
4. [Oral anticoagulant therapy--renaissance of an old therapy?].
Lechner K; Korninger C; Kyrle P; Geissler K; Niessner H; Pabinger I; Panzer S; Gössinger H; Bettelheim P; Hinterberger W
Wien Klin Wochenschr; 1987 Apr; 99(7):203-10. PubMed ID: 3590801
[TBL] [Abstract][Full Text] [Related]
5. Management of oral anticoagulant treatment in patients with venous thromboembolism.
Pengo V
Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
[TBL] [Abstract][Full Text] [Related]
6. [Role of laboratory monitoring in oral anticoagulant therapy].
D'Angelo G; Calvano D; Giardini C
Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
[TBL] [Abstract][Full Text] [Related]
7. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
Rombouts EK; Rosendaal FR; van der Meer FJ
Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
[TBL] [Abstract][Full Text] [Related]
8. When bleeding complicates oral anticoagulant therapy. How to anticipate, investigate, and treat.
Brigden ML
Postgrad Med; 1995 Sep; 98(3):153-4, 159-62, 164-5, passim. PubMed ID: 7675740
[TBL] [Abstract][Full Text] [Related]
9. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.
Halperin JL
J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
[TBL] [Abstract][Full Text] [Related]
11. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulant therapy: practical aspects of management.
Brigden ML
Postgrad Med; 1996 Jun; 99(6):81-4, 87-9, 93-4 passim. PubMed ID: 8668640
[TBL] [Abstract][Full Text] [Related]
13. Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors.
Hylek EM
Semin Vasc Med; 2003 Aug; 3(3):271-8. PubMed ID: 15199460
[TBL] [Abstract][Full Text] [Related]
14. Analysis and occurrence of adverse events with oral anticoagulant therapy.
Schenk JF; Mörsdorf S; Pindur G; Munter KH; Thrun F; Tiaden JD; Wenzel E
Semin Thromb Hemost; 1999; 25(1):65-71. PubMed ID: 10327223
[TBL] [Abstract][Full Text] [Related]
15. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
Abdelhafiz AH; Wheeldon NM
Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
[TBL] [Abstract][Full Text] [Related]
16. [Self-monitoring and self dosing of oral anticoagulant therapy with vitamin K antagonists].
Levi M; de Bruin TA; van der Meer FJ; Cromheecke ME; de Mol BA
Ned Tijdschr Geneeskd; 2001 Dec; 145(48):2313-7. PubMed ID: 11766299
[TBL] [Abstract][Full Text] [Related]
17. [Current biological surveillance of oral anticoagulant treatment].
Helft G; Vacheron A; Samama MM
Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
[TBL] [Abstract][Full Text] [Related]
18. [Bleeding complications of anticoagulant therapy].
Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
[TBL] [Abstract][Full Text] [Related]
19. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring of anticoagulant treatment in patients with cancer].
Mahé I; Bosquet A; Medjkane A; Bal dit Sollier C; Drouet L
Pathol Biol (Paris); 2008 Jun; 56(4):239-44. PubMed ID: 18407438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
